Research Paper Volume 16, Issue 3 pp 2563—2590
Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors
Figure 10. Coexpression of TPX2 with immune-associated genes in 31 cancer types from the TCGA database. (A) Heatmap of the association between TPX2 expression and chemokines. (B) Heatmap of the association between TPX2 expression and chemokine receptors. (C) Heatmap of the association between TPX2 expression and immune activation genes. (D) Heatmap of the association between TPX2 expression and immunosuppressive genes. (E) Heatmap of the association between TPX2 expression and MHC genes. (F) Heatmap of the association between TPX2 expression and DNA methyltransferases. (G) Heatmap of the association between TPX2 expression and MMRs genes.